Navigation Links
Ion Torrent Selected as World Economic Forum Technology Pioneer
Date:9/1/2010

.forumblog.org/techpioneers">http://www.forumblog.org/techpioneers
  • Press Releases at http://www.weforum.org/pressreleases

  • Follow Ion Torrent

    Become a fan on Facebook

    Check out our YouTube channel

    Follow us on Twitter

    About Ion Torrent

    Ion Torrent has developed a DNA sequencing system that directly translates chemical signals (A, C, G, T) into digital information (0, 1) on a semiconductor chip. The result is a sequencing system that is simpler, faster, less expensive and more scalable than any other technology available. Because Ion Torrent produces its proprietary semiconductor chips in standard CMOS factories, it leverages the $1 trillion investment that has been made in the semiconductor industry. Ion Torrent uniquely and directly benefits from four decades of exponential improvement in semiconductor technology, expressed as Moore's Law. Ion Torrent will launch the Ion Personal Genome Machine sequencer in 2010. Ion Torrent is based in Guilford, Conn., with an office in South San Francisco. For more information about Ion Torrent, visit www.iontorrent.com.


    '/>"/>
    SOURCE Ion Torrent
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Aeterna Zentaris: Perifosine Data Selected for Oral Presentation at Upcoming 12th World Congress on Gastrointestinal Cancer
    2. Genedata Phylosopher Selected for ERA-NET sncRNA Project
    3. NeoStem Selected to Present at American Society for Apheresis
    4. DNA Genoteks Oragene(R) DNA Product Selected by The Anthony Nolan Trust for Pilot Project
    5. OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
    6. Netsmart Technologies Selected by Douglas Gardens Community Mental Health to Provide Behavioral Health Software Solution
    7. BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council
    8. QuantaLife, Inc. Unanimously Selected as the Most Promising Company at the Personalized Medicine World Conference 2010
    9. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
    10. 4 ORNL researchers selected for Recovery Act early career funds
    11. Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... Francisco, CA (PRWEB) August 20, 2014 ... Conference is being held on October 29-30 in ... perspectives from industry, academic and government researchers and clinicians ... in the space. , In the twelve years ... one hundred therapies have been introduced with pharmacogenetic information ...
    (Date:8/20/2014)... GraphDB™ 6.0 from ... to the enterprise replication cluster, faster loading speeds, ... and Elasticsearch. This release happens to coincide with ... – GraphDB™ was formerly known as OWLIM. ... mature enterprise resilient RDF triplestore will also benefit ...
    (Date:8/19/2014)... 2014 Cellgen Diagnostics ... to fund a corporate lab for its genetic-based ... development is a critical component in the move ... the implementation of personalized medicine – a more ... , Indiegogo contributions will support Cellgen’s intent to ...
    (Date:8/19/2014)... Aug. 19, 2014 CSSi, the leader in ... announced the formation of the company,s Medical and Clinical ... addition of Dr. William E. Gannon, Jr. ... The MCAB, with Dr. Gannon,s ... therapeutic areas and set strategic goals for the advancement ...
    Breaking Biology Technology:6th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3
    ... ... Probiotics has released a case study that provides a sustainable solution ... evidence of the effectivness of beneficial microbial applications. These results are ... Environmental Protection Agency, who recently agreed to identify and investigate ...
    ... ... in new product launch of Chewy Bite Line expansion to include one of a kind ... Las Vegas, ... keep up with the demand to learn more about their new products at the ASMBS ...
    ... As previously announced on October 24th, 2009 delSECUR sold 100% ... Ontario company, QTECH SYSTEMS INC. in exchange for 49% of shares ... QTECH,s Management Team and the appointment of a new Chief Technology Officer, ... , , ...
    Cached Biology Technology:Effective Odor and Pathogen Control in Livestock Operations Revealed in New Case Study 2delSECUR CORPORATION Announces Organizational Update as QTECH SYSTEMS INC. Expands Leadership Team 2delSECUR CORPORATION Announces Organizational Update as QTECH SYSTEMS INC. Expands Leadership Team 3
    (Date:8/19/2014)... engineers have devised a new implantable tissue scaffold coated ... a few weeks. When applied to bone injuries or ... form new bone that looks and behaves just like ... could offer a dramatic improvement over the current standard ... another part of the patient,s body a painful ...
    (Date:8/19/2014)... neonatal abstinence syndrome (NAS) secondary to in-utero opioid ... withdrawal than others, but the underlying reasons are ... genes are turned on or off) changes have ... Boston University School of Medicine (BUSM) and Boston ... kind study to identify some of these epigenetic ...
    (Date:8/19/2014)... of today,s crocodiles colonised the seas during warm phases ... new Anglo-French study which establishes a link between marine ... a period of more than 140 million years. ... the Universit de Lyon, France and formerly from the ... Nature Communications ., Today, crocodiles are ,cold-blooded, animals ...
    Breaking Biology News(10 mins):Engineering new bone growth 2Engineering new bone growth 3In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2Evolution of marine crocodilians constrained by ocean temperatures 2
    ... the ongoing mission to train and educate scientists on ... J. Craig Venter Institute,s (JCVI) Eukaryotic Genome Annotation and ... to train 40 United States Agriculture Department (USDA) scientists ... session will focus on the use of JCVI,s eukaryotic ...
    ... Langone Medical Center may have discovered a new targeted ... disease, is a serious genetic disorder occurring predominantly in ... childhood. The new study entitled, "Role of calcium-independent phospholipase ... published in the Proceedings of the National Academy ...
    ... to the successful implantation of a fertilized human egg. ... of the implantation can all affect the outcome of ... University researcher is suggesting that prospective parents and their ... other biomechanical processes play in its success. New studies ...
    Cached Biology News:JCVI program trains USDA scientists on eukaryotic genome analysis 2New potential therapeutic target discovered for genetic disorder -- Barth syndrome 2Engineering bouncing babies, 1 at a time 2
    Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
    Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
    Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected....
    ...
    Biology Products: